MedTrace Logo

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

NCT00463034 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2013-12-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and help doctors understand how patients respond to treatment.

PURPOSE: This clinical trial is assessing how changes in genes affect disease progression in women with newly diagnosed or metastatic breast cancer.

Conditions

Interventions

GENETIC

microarray analysis

GENETIC

polymerase chain reaction

GENETIC

polymorphism analysis

OTHER

high performance liquid chromatography

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

questionnaire administration

Sponsors & Collaborators

  • University of Sheffield

    lead OTHER

Principal Investigators

  • Angela Cox, PhD · University of Sheffield

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2008-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00463034 on ClinicalTrials.gov